| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1003221 |
| landingPage: |
http://www.iedb.org/assay/1350267 |
| type: |
Literature
|
| publicationVenue: |
Vaccine
|
| dates: |
2001
|
| study type: | b cell assays |
| subject species: | Hepatitis B virus |
| fullName: |
J S Moynihan
D H Jones
G H Farrar
C R Howard
|
| method: |
ELISA
|
| name: |
A novel microencapsulated peptide vaccine against hepatitis B.
|
| description: |
Similar antibody responses to the epitope were observed after immunization with the epitope encapsulated in polyactide co-glycolide microspheres (PLG) at two ratios (50:50 or 75:25) or in Freund's complete adjuvant. The primary IgG subclass was IgG1 with lesser amounts of IgG2a and low levels of IgG2b and IgG3. The epitope also blocked binding of anti-epitope sera to the epitope and to HBVsAg.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |